These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34090300)

  • 1. CORRUPTIVE INCOMINGS LAUNDERING IN THE MEDICAL SPHERE.
    Reznik OМ; Bondarenko OS; Utkina MS; Horobets NS
    Wiad Lek; 2021; 74(5):1250-1255. PubMed ID: 34090300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corruption in medical sphere of Ukraine: current situation and ways of prevention.
    Batyrgareieva VS; Babenko AM; Kaija S
    Wiad Lek; 2019; 72(9 cz 2):1814-1821. PubMed ID: 31622272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is money laundering a true problem in China?
    Ping H
    Int J Offender Ther Comp Criminol; 2006 Feb; 50(1):101-16. PubMed ID: 16397125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of organization and end-user computing-anti-money laundering monitoring and analysis system security control.
    Sun L
    PLoS One; 2021; 16(12):e0258627. PubMed ID: 34882687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How much demand for money laundering services does drug selling create? Identifying the key parameters.
    Caulkins JP; Reuter P
    Int J Drug Policy; 2022 May; 103():103652. PubMed ID: 35334339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CORRUPTION OFFENCES IN MEDICATIONS CIRCULATION: INVESTIGATION PROBLEMS.
    Latysh KV; Demidova YE
    Wiad Lek; 2021; 74(11 cz 2):2896-2900. PubMed ID: 35029552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating money laundering flows with a gravity model-based simulation.
    Ferwerda J; van Saase A; Unger B; Getzner M
    Sci Rep; 2020 Oct; 10(1):18552. PubMed ID: 33122829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Making sense of professional enablers' involvement in laundering organized crime proceeds and of their regulation.
    Levi M
    Trends Organ Crime; 2021; 24(1):96-110. PubMed ID: 33262562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies to avoid blacklisting: The case of statistics on money laundering.
    Ferwerda J; Deleanu IS; Unger B
    PLoS One; 2019; 14(6):e0218532. PubMed ID: 31242211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the Control of Money Laundering and Its Underlying Offences: the Search for Meaningful Data.
    Levi M
    Asian J Criminol; 2020; 15(4):301-320. PubMed ID: 32837603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Legal ivory trade in a corrupt world and its impact on African elephant populations.
    Bennett EL
    Conserv Biol; 2015 Feb; 29(1):54-60. PubMed ID: 25103555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leveraging machine learning in the global fight against money laundering and terrorism financing: An affordances perspective.
    Canhoto AI
    J Bus Res; 2021 Jul; 131():441-452. PubMed ID: 33100427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do Countries Consistently Engage in Misinforming the International Community about Their Efforts to Combat Money Laundering? Evidence Using Benford's Law.
    Deleanu IS
    PLoS One; 2017; 12(1):e0169632. PubMed ID: 28122058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining Benford's Law and machine learning to detect money laundering. An actual Spanish court case.
    Badal-Valero E; Alvarez-Jareño JA; Pavía JM
    Forensic Sci Int; 2018 Jan; 282():24-34. PubMed ID: 29149684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National assessments of money laundering risks: Stumbling at the start.
    Ferwerda J; Reuter P
    Risk Anal; 2024 Apr; ():. PubMed ID: 38637278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Legal regulation of the production and trade of medical devices and medical equipment in the EU and US: experience for Ukraine.
    Pashkov V; Kotvitska A; Harkusha A
    Wiad Lek; 2017; 70(3 pt 2):614-618. PubMed ID: 28713093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improper healthcare marketing: German and Ukrainian experience in prevention.
    Gutorova N; Soloviov O; Olejnik D
    Wiad Lek; 2019; 72(12 cz 2):2404-2409. PubMed ID: 32124760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Falsification of medical products: criminal law mechanism combating threats to public health.
    Gutorova N; Zhytnyi O; Soloviov O
    Wiad Lek; 2019; 72(5 cz 1):856-861. PubMed ID: 31175785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [MECHANISM OF PUBLIC PROCUREMENTS IN THE HEALTHCARE SPHERE IN THE EUROPEAN UNION AND UKRAINE: FINANCIAL AND LEGAL ASPECT].
    Dmytrenko E; Kharchenko V; Shcherbakovskyi M; Ozerskyi I; Popovich E
    Georgian Med News; 2019 Jun; (291):130-136. PubMed ID: 31418746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.